🔎 Trials Near Me

Home › Graft-Versus-Host Disease › Massachusetts › Boston

Graft-Versus-Host Disease clinical trials in Boston, MA

10 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Recruiting
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06910969

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

RecruitingPhase 1
  • Dana-Farber Cancer Institute, Boston
Ages 2 and older · All sexes · Updated Jul 23, 2026 · NCT06991361

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

RecruitingPhase 2
  • Massachusetts General Hospital, Boston
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

RecruitingPhase 3
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

RecruitingPhase 2
  • Boston Children's Hospital, Boston
Ages 2 and older · All sexes · Updated May 11, 2026 · NCT04380740

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

Recruiting
  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT05236062

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

RecruitingPhase 2
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

RecruitingObservational study
  • Dana Farber, Boston
36 Months · All sexes · Updated Oct 20, 2025 · NCT05866302

IS-free Treg HaploHCT

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 18 to 75 · All sexes · Updated Oct 20, 2025 · NCT04678401

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

RecruitingPhase 1
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365

Graft-Versus-Host Disease trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.